期刊文献+

C反应蛋白与白蛋白比值对Ⅰb~Ⅱa期宫颈癌术后复发的预测价值

The Predictive Value of the Ratio of C-reactive Protein to Albumin for Postoperative Recurrence of StageⅠb~Ⅱa Cervical Cancer
原文传递
导出
摘要 目的探讨C反应蛋白与白蛋白比值(CAR)对Ⅰb~Ⅱa期宫颈癌术后复发的预测价值。方法选取2017年11月至2018年11月北部战区总医院收治的宫颈癌行手术治疗患者84例作为研究对象,依据患者随访期间的预后转归情况,分为预后良好组57例、预后不良组27例。收集所有患者术前24 h的临床病理资料,包括年龄、体重指数(BMI)、临床分期、肿瘤大小、病理类型、手术方式、是否辅助化疗、淋巴结转移情况、是否保留卵巢和实验室指标[血清C-反应蛋白(CRP)、白蛋白(ALB)、同型半胱氨酸(Hcy)、中性粒细胞数、单核细胞计数、淋巴细胞计数],并计算全身炎症指数(SIRI)、CAR。并对上述指标进行对比分析,单因素筛查有意义指标行多因素Logistic回归分析,对CAR采用受试者工作特征曲线(ROC)进行分析。结果预后良好组与预后不良组患者年龄、BMI、临床分期、是否辅助化疗、淋巴结转移情况、术后是否保留卵巢差异无统计学意义(P>0.05);预后良好组与预后不良组患者肿瘤大小、病理类型、CRP、ALB、Hcy、SIRI、CAR比较差异有统计学意义(P<0.05)。多因素Logistic回归分析显示,SIRI、CAR是影响宫颈癌患者术后复发的重要因素(P<0.05)。术前24 h的CAR值对宫颈癌患者术后复发的判断价值的ROC下面积为0.858,NPR最佳界值为2.950,敏感度为0.815,特异度为0.930,约登指数为0.745。结论肿瘤直径≥4 cm、腺癌、高CRP、高Hcy、高SIRI、高CAR及低ALB均为宫颈癌术后复发的重要影响因素,对疾病的预后及复发有较好的预测价值。SIRI及CAR可作为预测宫颈癌患者术后复发的独立危险因素。CAR在预测宫颈癌患者术后复发方面具有较好的敏感性和特异性。 Objective To explore the predictive value of the ratio of C-reactive protein to albumin(CAR)for postoperative recurrence of stageⅠb~Ⅱa cervical cancer.Methods A total of 84 patients who underwent surgical treatment for cervical cancer admitted to the Northern Theater General Hospital from November 2017 to November 2018 were selected as the study objects.According to the prognosis of the patients during follow-up,they were divided into a good prognosis group(57 cases)and a poor prognosis group(27 cases).Clinicopathological data,which include age,body mass index(BMI),clinical stage,tumor size,pathological type,surgical method,adjuvant chemotherapy,lymph node metastasis,ovarian preservation and laboratory indicators[serum C-reactive protein(CRP),albumin(ALB),homocysteine(Hcy),neutrophil count,monocyte count,and lymphocyte count],of all patients 24 h before surgery were collected,the systemic inflammation index(SIRI)and CAR were calculated.Multivariate Logistic regression analysis was performed for meaningful indicators of single factor screening,and receiver operating characteristic curve(ROC)was used to analyze CAR.Results There were no significant differences in age,BMI,clinical stage,adjuvant chemotherapy,lymph node metastasis,and postoperative ovarian preservation between the good prognosis group and the poor prognosis group(P>0.05).There were significant differences in tumor size,pathological type,CRP,ALB,Hcy,SIRI and CAR between the good prognosis group and the poor prognosis group(P<0.05).Multivariate Logistic regression analysis showed that SIRI and CAR were important factors affecting postoperative recurrence of cervical cancer patients(P<0.05).The area under ROCcurve of CAR value 24 h before surgery was 0.858,the optimal threshold of NPR was 2.950,the sensitivity was 0.815,the specificity was 0.930,and the Yoden index was 0.745 in the judgment of postoperative recurrence of cervical cancer.Conclusion Tumor diameter≥4 cm,adenocarcinoma,high CRP,high Hcy,high SIRI,high CAR and low ALB are all important factors for postoperative recurrence of cervical cancer,and have good predictive value for the prognosis and recurrence of the disease.SIRI and CAR can be used as independent risk factors for predicting postoperative recurrence of cervical cancer.CAR has good sensitivity and specificity in predicting postoperative recurrence of cervical cancer.
作者 王立平 侯丹 WANG Li-Ping;HOU Dan(Department of Health Medicine,Northern Theater Command General Hospital,Shenyang 110000,China)
出处 《中国药物经济学》 2023年第11期99-103,共5页 China Journal of Pharmaceutical Economics
关键词 宫颈癌术后 C反应蛋白与白蛋白比值 复发 Postoperative cervical cancer Ratio of C-reactive protein to albumin Recrudescence
  • 相关文献

参考文献21

二级参考文献148

  • 1李莹,陈志红,周北凡,李义和,武阳丰,刘小清,赵连成,麦劲壮,杨军,石美玲,田秀珍,关渭全,于学海,陈磊.血脂和脂蛋白水平对我国中年人群缺血性心血管病事件的预测作用[J].中华心血管病杂志,2004,32(7):643-647. 被引量:326
  • 2卞美璐.WHO(2006年)宫颈癌综合防治实践指南简介[J].中国实用妇科与产科杂志,2007,23(7):557-560. 被引量:106
  • 3Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
  • 4Shi JF, Canfell K, Lew JB, et al. The burden of cervical cancer in China: synthesis of the evidence [J]. Int J Cancer, 2012, 130(3): 641-652.
  • 5Duk JM, Groenier KH, de Bruijn HW, et al. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma [ J ]. J Clin Oncol, 1996, 14 ( 1 ) : 111-118.
  • 6Gadducci A, Tana R, Fanucchi A, et al. Biochemical prognostic factors and risk of relapses in patients with cervical cancer[J]. Gynecol Oncol, 2007, 107(1 Suppl 1) : $23-$26.
  • 7Strauss HG, Laban C, Lautenschlager C, et al. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix [Jl.Eur J Cancer, 2002, 38 (15) : 1987- t991.
  • 8Bolger BS, Dabbas M, Lopes A, et al. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma [J]. Gynecol Oncol, 1997, 65(2) : 309-313.
  • 9Lukaszewicz-Zajac M, Mroczko B, Kozlowski M, et al. Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus) [Jl. J Clin Lab Anal, 2012, 26(2): 73-81.
  • 10Minamiya Y, Miura M, Hinai Y, et al. The CRP 1846T/T genotype is associated with a poor prognosis in patients with non-small cell lung cancer [J]. Turnout Biol, 2010, 31(6): 673-679.

共引文献610

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部